The Association of American Cancer Institutes (AACI) comprises 98 premier academic and freestanding cancer research centers in the U.S. and Canada. AACI is dedicated to reducing the burden of cancer by enhancing the impact of North America’s leading academic cancer centers.
Acting as a network for research leaders, Clinical Research Innovation (CRI) promotes the efficient operation of clinical research facilities at AACI cancer centers.
The AACI Government Relations Forum facilitates an improved understanding of policy issues as they pertain to cancer prevention, treatment, and survivorship.
Roy A. Jensen, MD, has been the director of The University of Kansas Cancer Center since 2004. Under his leadership, KU Cancer Center earned designation from the National Cancer Institute in 2012.
Dr. Jensen has lectured widely on the clinical and molecular aspects of breast cancer pathology. His research focuses on understanding the function of BRCA1 and BRCA2 and their role in breast and ovarian neoplasia; and on the characterization of premalignant breast disease.
A member of AACI's board of directors since 2013, Dr. Jensen began his term as president in October 2018.
The AACI Presidential Initiative allows the president of AACI's Board of Directors to formalize a special project of broad interest and value to AACI members during their two-year term. Several of AACI's signature programs began as presidential initiatives.
For his presidential initiative, Roy A. Jensen, MD, developed a comprehensive, cancer-specific library of model legislation and public policy resources. The AACI Public Policy Resource Librarywill address issues ranging from state funding for cancer research to HPV vaccination and tobacco regulation.